The Therapeutic Goods Administration (TGA) has approved Pfizer Australia and BioNTech SE’s XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) for individuals aged 5 and over. The decision follows evidence that this vaccine can better protect against symptomatic and severe COVID-19. The vaccine is free and available at pharmacies and general practices across Australia.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
